Search - tctmd.com

Displaying 341 - 360 of 414

Sort: Relevancy | Date

Presentation TCT 2012

Tough Call During an LAA Occlusion

Presenter: Vivek Reddy

October 24, 2012

Presentation TCT 2012

The SentreHeart Transpericardial Approach to LAA Occlusion

Presenter: Steven Yakubov

October 24, 2012

Presentation TCT 2012

Surgical LAA Exclusion: Is It Effective?

Presenter: A. Marc Gillinov

October 24, 2012

Presentation TCT 2012

Next-Generation LAA Occlusion Devices: AMPLATZER (St. Jude Medical) and WAVECREST (Coherex Medical)

Presenter: Horst Sievert

October 24, 2012

Presentation TCT 2012

Closure of the Left Atrial Appendage: Transcatheter Approaches and Results

Presenter: Randall Lee

October 24, 2012

Presentation TCT 2012

Closure of the Left Atrial Appendage: Surgical Approaches and Results

Presenter: A. Marc Gillinov

October 24, 2012

Presentation TCT 2012

WaveCrest (Coherex Medical): Device Iteration, Human Outcomes, and Clinical Trial Directions

Presenter: Saibal Kar

October 23, 2012

Presentation TCT 2012

WATCHMAN Tips and Tricks

Presenter: Peter Sick

October 23, 2012

Presentation TCT 2012

Various Techniques for Surgical LAA Closure (With and Without Thoracoscopy): Acute and Long-term Outcomes

Presenter: A. Marc Gillinov

October 23, 2012

Presentation TCT 2012

The Spectrum of Late Complications of LAA Closure: Device-Specific Mechanisms, Incidence, and Prevention

Presenter: Peter Block

October 23, 2012

Presentation TCT 2012

The Spectrum of Early Complications of LAA Closure: Have They Been Eliminated?

Presenter: David Holmes Jr

October 23, 2012

Presentation TCT 2012

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

The New Anticoagulants: A Meaningful Step Forward?

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

Presenter: Saibal Kar

October 23, 2012

Presentation TCT 2012

TCT-83. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients with Contraindication to Oral Anticoagulation: the “Aspirin Plavix Registry” (ASAP)

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

Synthesis of the New ESC LAA Closure Guidelines

Presenter: Peter Sick

October 23, 2012

Presentation TCT 2012

Quality-of-Life and Cost-Effectiveness After LAA Closure

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

Prevail Study: Design and Current Status

Presenter: Saibal Kar

October 23, 2012

Presentation TCT 2012

PFM Medical: Device Description and Preclinical Results

Presenter: Alexander Javois

October 23, 2012

Presentation TCT 2012

Outcomes and Insights from the European ACP Registry

Presenter: Jai-Wun Park

October 23, 2012

Advertisement

Tough Call During an LAA Occlusion

The SentreHeart Transpericardial Approach to LAA Occlusion

Surgical LAA Exclusion: Is It Effective?

Next-Generation LAA Occlusion Devices: AMPLATZER (St. Jude Medical) and WAVECREST (Coherex Medical)

Closure of the Left Atrial Appendage: Transcatheter Approaches and Results

Closure of the Left Atrial Appendage: Surgical Approaches and Results

WaveCrest (Coherex Medical): Device Iteration, Human Outcomes, and Clinical Trial Directions

WATCHMAN Tips and Tricks

Various Techniques for Surgical LAA Closure (With and Without Thoracoscopy): Acute and Long-term Outcomes

The Spectrum of Late Complications of LAA Closure: Device-Specific Mechanisms, Incidence, and Prevention

The Spectrum of Early Complications of LAA Closure: Have They Been Eliminated?

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

The New Anticoagulants: A Meaningful Step Forward?

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

TCT-83. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients with Contraindication to Oral Anticoagulation: the “Aspirin Plavix Registry” (ASAP)

Synthesis of the New ESC LAA Closure Guidelines

Quality-of-Life and Cost-Effectiveness After LAA Closure

Prevail Study: Design and Current Status

PFM Medical: Device Description and Preclinical Results

Outcomes and Insights from the European ACP Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content